HII vs DRS vs BWXT
161 measures in 16 categories, one definition each, computed from filings and market data.
HII45.6
Huntington Ingalls Industries, Inc.
Industrials · Aerospace & Defense
$272.00 +1.75%$10.7B mkt cap
Score DNA
BWXT63.4
BWX Technologies, Inc.
Industrials · Aerospace & Defense
$137.01 −0.17%$12.6B mkt cap
Score DNA
Price, rebased to 100 three years ago
HII DRS BWXT · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 1 | 0 |
| Insider $ bought, 180d | — | $1.07M | — |
| Congress purchases, 180d | 0 | 0 | 23 |
| Last Congress purchase | — | — | 2026-08-03 |
| 13F net change in holders | −86 | +38 | +26 |
| ETFs adding shares, 30d | 503 | 236 | 320 |
| ETFs trimming, 30d | 390 | 205 | 237 |
| Net ETF funds, 30d | +113 | +31 | +83 |
Valuation
16 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| P/E (TTM) | 16.2x
3rd
|
29.4x
36th
|
35.3x
62nd
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 1.89
62nd
|
— | 2.14
71st
|
| Price / sales | 0.8x
4th
|
2.5x
33rd
|
3.6x
47th
|
| Price / book | 2.0x
21st
|
3.4x
43rd
|
9.4x
81st
|
| Price / tangible book | 5.5x
32nd
|
7.8x
44th
|
33.9x
83rd
|
| Price / free cash flow | 28.5x
43rd
|
26.0x
37th
|
39.6x
60th
|
| Price / operating cash flow | 30.9x
54th
|
18.9x
31st
|
24.2x
41st
|
| Enterprise value | $13.6B
64th
|
$9.5B
58th
|
$14.0B
65th
|
| EV / sales | 1.0x
9th
|
2.5x
31st
|
4.0x
47th
|
| EV / EBITDA | 11.4x
12th
|
19.1x
45th
|
25.2x
69th
|
| EV / EBIT | 15.7x
10th
|
23.7x
41st
|
32.1x
67th
|
| EV / free cash flow | 36.3x
46th
|
26.0x
37th
|
44.1x
63rd
|
| Earnings yield | 6.2%
98th
|
3.4%
75th
|
2.8%
56th
|
| FCF yield | 3.5%
73rd
|
3.8%
76th
|
2.5%
62nd
|
| Operating cash flow yield | 3.2%
62nd
|
5.3%
78th
|
4.1%
71st
|
| Graham number (per share) | $225.02
97th
|
$16.76
24th
|
$35.50
45th
|
Profitability (TTM)
12 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| Gross margin | 12.6%
13th
|
24.9%
43rd
|
22.1%
39th
|
| EBITDA margin | 9.0%
36th
|
13.1%
55th
|
15.7%
66th
|
| Operating margin | 5.2%
36th
|
10.5%
62nd
|
9.7%
51st
|
| EBIT margin | 6.6%
40th
|
10.6%
58th
|
12.4%
74th
|
| Net margin | 5.0%
38th
|
8.5%
70th
|
10.1%
75th
|
| NOPAT margin | 4.1%
36th
|
8.7%
66th
|
8.0%
51st
|
| FCF margin | 2.9%
36th
|
9.6%
72nd
|
9.0%
70th
|
| Operating cash flow margin | 2.6%
30th
|
13.3%
68th
|
14.8%
77th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.4%
38th
|
| SG&A / revenue | 7.5%
23rd
|
13.7%
51st
|
12.0%
43rd
|
| Stock comp / revenue | 0.4%
22nd
|
0.7%
44th
|
0.9%
61st
|
| Effective tax rate | 21.7%
80th
|
17.0%
27th
|
17.1%
33rd
|
Returns on capital
11 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| ROE (on average equity) | 13.0%
67th
|
11.9%
59th
|
28.2%
86th
|
| ROA | 5.3%
60th
|
7.8%
69th
|
8.7%
76th
|
| ROIC | 6.5%
44th
|
11.8%
65th
|
10.3%
60th
|
| ROCE | 8.7%
49th
|
12.7%
73rd
|
11.7%
67th
|
| Return on tangible assets | 7.0%
55th
|
9.6%
65th
|
10.7%
73rd
|
| Cash ROIC (OCF / invested capital) | 4.2%
33rd
|
17.9%
76th
|
18.9%
78th
|
| Gross profitability (GP / assets) | 13.1%
36th
|
22.3%
78th
|
17.5%
60th
|
| ROIC, 3-yr average | 7.2%
41st
|
8.3%
46th
|
12.0%
87th
|
| ROIC, 5-yr average | 9.5%
56th
|
10.0%
61st
|
16.3%
90th
|
| ROE, 5-yr average | 15.0%
80th
|
11.2%
59th
|
29.8%
95th
|
| Incremental ROIC | 27.1%
50th
|
— | 5.9%
38th
|
Growth
17 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| Revenue growth (TTM YoY) | 14.0%
33rd
|
10.5%
22nd
|
22.7%
61st
|
| Revenue growth (QoQ) | 10.3%
51st
|
7.9%
44th
|
4.7%
29th
|
| Revenue CAGR, 3 yr | 6.6%
24th
|
12.5%
43rd
|
14.7%
54th
|
| Revenue CAGR, 5 yr | 6.6%
21st
|
5.6%
19th
|
10.7%
47th
|
| Gross profit CAGR, 3 yr | 4.8%
24th
|
16.5%
60th
|
11.2%
38th
|
| Operating income CAGR, 3 yr | 10.8%
32nd
|
-9.1%
6th
|
-1.6%
15th
|
| Net income growth (TTM YoY) | 25.9%
39th
|
28.8%
42nd
|
20.7%
33rd
|
| Net income CAGR, 3 yr | 8.3%
30th
|
-6.3%
7th
|
16.6%
43rd
|
| EPS growth (TTM YoY) | 25.6%
39th
|
28.8%
42nd
|
20.3%
31st
|
| EPS CAGR, 3 yr | 8.6%
33rd
|
-6.8%
7th
|
16.5%
47th
|
| EPS CAGR, 5 yr | -2.1%
15th
|
7.2%
42nd
|
6.6%
35th
|
| FCF growth (TTM YoY) | -59.1%
0th
|
54.5%
61st
|
-12.1%
23rd
|
| FCF CAGR, 3 yr | 1.3%
9th
|
— | 67.6%
95th
|
| Operating cash flow CAGR, 3 yr | -19.1%
3rd
|
— | 29.3%
55th
|
| Book value CAGR, 3 yr | 13.7%
64th
|
7.9%
45th
|
16.5%
68th
|
| Dividend CAGR, 3 yr | 1.2%
28th
|
25.2%
100th
|
1.8%
38th
|
| Sustainable growth rate | 8.7%
39th
|
8.4%
37th
|
20.6%
82nd
|
Margin history & stability
7 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| Gross margin, 3-yr average | 13.2%
13th
|
23.5%
37th
|
23.9%
41st
|
| Operating margin, 3-yr average | 5.4%
33rd
|
9.5%
54th
|
12.9%
76th
|
| Net margin, 3-yr average | 5.3%
41st
|
7.3%
61st
|
10.2%
76th
|
| FCF margin, 3-yr average | 4.6%
48th
|
8.1%
63rd
|
10.4%
83rd
|
| Revenue stability (0-1) | 0.92
58th
|
0.68
19th
|
0.88
42nd
|
| Earnings stability (0-1) | 0.04
2nd
|
0.31
23rd
|
0.27
21st
|
| Margin stability (0-1) | 0.86
45th
|
0.90
62nd
|
0.94
72nd
|
Liquidity (latest quarter)
7 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| Cash & short-term investments | $12.0M
2nd
|
$270.0M
44th
|
$608.2M
69th
|
| Net cash (− = net debt) | −$2.9B
22nd
|
$3.0M
69th
|
−$1.4B
31st
|
| Working capital | $606.0M
42nd
|
$975.0M
55th
|
$996.8M
56th
|
| Current ratio | 1.23
13th
|
1.92
33rd
|
2.40
47th
|
| Quick ratio | 1.14
27th
|
1.56
49th
|
2.33
71st
|
| Cash ratio (cash + ST investments / current liabilities) | 0.00
0th
|
0.25
42nd
|
0.85
64th
|
| Defensive interval (days) | 284 days
4th
|
401 days
9th
|
1,273 days
72nd
|
Leverage & solvency (latest quarter)
13 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| Total debt | $2.9B
76th
|
$267.0M
31st
|
$2.0B
69th
|
| Debt / equity | 0.55
57th
|
0.10
21st
|
1.51
85th
|
| Net debt / equity | 0.55
70th
|
−0.00
32nd
|
1.06
89th
|
| Debt / assets | 23.1%
44th
|
6.4%
20th
|
45.7%
85th
|
| Debt / capital | 35.6%
57th
|
8.7%
21st
|
60.2%
85th
|
| Debt / EBITDA | 2.46
55th
|
0.54
10th
|
3.65
76th
|
| Net debt / EBITDA | 2.45
62nd
|
−0.01
19th
|
2.55
64th
|
| Interest coverage (EBIT / interest) | 19.8x
92nd
|
79.8x
98th
|
12.6x
81st
|
| Cash interest coverage | 7.9x
62nd
|
100.2x
98th
|
15.1x
83rd
|
| Debt payback (years of OCF) | 8.5 yrs
85th
|
0.5 yrs
10th
|
3.9 yrs
64th
|
| Liabilities / assets | 58.1%
64th
|
33.2%
25th
|
69.8%
80th
|
| IS credit model rating | A- | AAA | AA- |
| Implied credit spread (bps) | 175
47th
|
50
0th
|
100
22nd
|
Efficiency
11 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| Asset turnover | 1.06
87th
|
0.91
76th
|
0.87
73rd
|
| Fixed asset turnover | 3.23
30th
|
7.18
72nd
|
2.19
26th
|
| Inventory turnover | 51.1
96th
|
7.3
72nd
|
56.0
98th
|
| Receivables turnover | 10.0
78th
|
12.9
89th
|
17.1
96th
|
| Days sales outstanding | 37 days
24th
|
28 days
13th
|
21 days
5th
|
| Days inventory outstanding | 7 days
4th
|
50 days
28th
|
7 days
2nd
|
| Days payables outstanding | 22 days
0th
|
29 days
20th
|
27 days
13th
|
| Cash conversion cycle (days) | 22 days
18th
|
50 days
31st
|
1 days
13th
|
| Capex / revenue | — | 3.7%
53rd
|
5.8%
70th
|
| Capex / depreciation | — | 1.42
65th
|
1.71
67th
|
| Operating expense ratio | 7.1%
12th
|
14.8%
44th
|
12.5%
33rd
|
Cash flow & earnings quality
7 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| Operating cash flow / net income | 0.52
15th
|
1.56
69th
|
1.46
62nd
|
| FCF / net income | 0.57
21st
|
1.13
64th
|
0.89
51st
|
| FCF / operating cash flow | — | 72.5%
53rd
|
61.0%
21st
|
| Capex / operating cash flow | — | 27.5%
47th
|
39.0%
79th
|
| Accruals ratio | 2.5%
91st
|
-4.3%
29th
|
-4.0%
33rd
|
| Sloan accruals ratio | 0.5%
58th
|
-4.6%
31st
|
11.6%
82nd
|
| Earnings quality score (0-1) | 0.50
15th
|
1.00
49th
|
1.00
49th
|
Scores & forensic checks
15 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| IS score | 46
38th
|
70
89th
|
63
67th
|
| IS profitability | 28
44th
|
39
62nd
|
49
76th
|
| IS growth | 68
45th
|
65
35th
|
74
63rd
|
| IS value | 59
93rd
|
44
55th
|
36
35th
|
| IS momentum | 70
29th
|
91
73rd
|
96
90th
|
| IS risk (safety) | 65
18th
|
100
44th
|
100
44th
|
| IS quality | 55
42nd
|
77
89th
|
67
55th
|
| IS balance sheet | 59
53rd
|
80
87th
|
64
60th
|
| IS earnings quality | 69
64th
|
83
96th
|
67
47th
|
| IS cash flow | 27
16th
|
78
98th
|
49
55th
|
| Piotroski F-score (0-9) | 7
53rd
|
7
53rd
|
6
31st
|
| Altman Z-score | 2.9
27th
|
5.7
67th
|
5.7
64th
|
| Beneish M-score | −2.92
16th
|
−3.33
12th
|
−2.53
32nd
|
| Ohlson O-score | −7.56
56th
|
−9.53
11th
|
−6.99
67th
|
| IS credit score | 68
47th
|
97
96th
|
82
71st
|
Size (TTM)
8 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| Market cap | $10.7B
60th
|
$9.5B
58th
|
$12.6B
65th
|
| Revenue | $13.2B
84th
|
$3.8B
64th
|
$3.5B
60th
|
| EBITDA | $1.2B
78th
|
$496.0M
58th
|
$553.3M
60th
|
| Net income | $661.0M
78th
|
$322.0M
60th
|
$355.3M
64th
|
| Free cash flow | $376.0M
73rd
|
$363.0M
71st
|
$316.8M
69th
|
| Total assets | $12.7B
80th
|
$4.2B
53rd
|
$4.4B
56th
|
| Shareholders' equity | $5.3B
84th
|
$2.8B
65th
|
$1.3B
45th
|
| Employees | 45,000
85th
|
7,300
60th
|
10,400
67th
|
Price performance
9 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| 1 day | +1.8% | −0.1% | −0.2% |
| 1 week | +2.7% | −2.3% | −4.8% |
| 1 month | −1.9% | −4.4% | −6.4% |
| 3 months | +0.7% | −20.2% | −19.2% |
| 6 months | −31.1% | −20.5% | −41.9% |
| Year to date | −22.0% | +1.8% | −24.7% |
| 1 year | −4.2% | −11.6% | −32.7% |
| 3 years, cumulative | +29.7% | +96.0% | +80.6% |
| 5 years, cumulative | +45.0% | +232.0% | +149.8% |
Technicals
4 measures| Measure | HII | DRS | BWXT |
|---|---|---|---|
| RSI 14 | 50.8 | 36.3 | 41.1 |
| From 52-week high | −40.9% | −30.0% | −43.4% |
| From 52-week low | +6.5% | +9.2% | +4.1% |
| Beta | 0.21 | 0.18 | 0.74 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17